MIRA INFORM REPORT

 

 

Report Date :

18.04.2012

 

IDENTIFICATION DETAILS

 

Name :

HARMAN FINOCHEM LIMITED

 

 

Registered Office :

107-A, Vinay Bhavya Complex, 159 A CST Road, Kalina Santacruz (East), Mumbai – 400 098, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2011

 

 

Date of Incorporation :

17.03.1983

 

 

Com. Reg. No.:

11-29560

 

 

Capital Investment / Paid-up Capital :

Rs.47.636 Millions

 

 

CIN No.:

[Company Identification No.]

U24110MH1983PLC029560

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacturing and Sale of Bulk Drugs and Pharmaceuticals

 

 

No. of Employees :

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (50)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 4600000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having satisfactory track. Trade relations are reported as fair. Business is active. Payments are reported to be regular and as per commitments.

 

The company can be considered normal for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – September 30, 2011

 

Country Name

Previous Rating

(30.06.2011)

Current Rating

(30.09.2011)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

 

 

 

 

 

 

 

 

 

 

 


 

LOCATIONS

 

Registered Office :

107-A, Vinay Bhavya Complex, 159 A CST Road, Kalina Santacruz (East), Mumbai – 400098, Maharashtra, India

Tel. No.:

91-22-26528080 / 67330100

Fax No.:

91-22-26528285

E-Mail :

harmanfinochem@vsnl.com

Info@harmanfinochem.com

Website :

http://www.harmanfinochem.com

 

 

DIRECTORS

As on 30.09.2011

 

Name :

Mr. Bhupinder Singh Manhas

Designation :

Managing Director

Address :

107-A, Vinaya Bhavya Complex, 159-A, CST Road, Kalina, Santacruz (East), Mumbai – 400 098, Maharashtra, India

Date of Birth/Age :

01.04.1950

Date of Appointment :

17.03.1983

DIN No.:

00121253

Other Directorship:

 

S.No.

CIN

Name of the Company

Current designation of the director

Date of appointment at current designation

Original date of appointment

Date of cessation

Company Status

Defaulting status

1

U24110MH1983PLC029560

HARMAN FINOCHEM LIMITED

Managing director

17/03/1983

17/03/1983

-

Active

NO

2

U24230MH1989PTC132889

WELL WORTH MEDICINES PRIVATE LIMITED

Director

31/10/1996

31/10/1996

-

Active

NO

3

U30005MH1995PTC084585

SANSKAR INFO TV PRIVATE LIMITED

Additional director

8/9/2010

8/9/2010

-

Active

NO

 

 

Name :

Ms. Inderjeet Kaur Manhas

Designation :

Director

Address :

107-A, Vinaya Bhavya Complex, 159-A, CST Road, Kalina, Santacruz (East), Mumbai – 400 098, Maharashtra, India

Date of Birth/Age :

23.10.1951

Date of Appointment :

11.02.1997

DIN No.:

00121284

Other Directorship:

 

 

S.No.

CIN

Name of the Company

Current designation of the director

Date of appointment at current designation

Original date of appointment

Date of cessation

Company Status

Defaulting status

1

U24230MH1989PTC132889

WELL WORTH MEDICINES PRIVATE LIMITED

Director

15/07/1996

15/07/1996

-

Active

NO

2

U24110MH1983PLC029560

HARMAN FINOCHEM LIMITED

Director

11/2/1997

11/2/1997

-

Active

NO

3

U25202MH1984PTC197665

KIRTI MERCHANTILE PRIVATE LIMITED

Director

2/1/2006

2/1/2006

-

Active

NO

 

 

Name :

Mr. Harpreet Singh Manhas

Designation :

Director

Address :

107-A, Vinaya Bhavya Complex, 159-A, CST Road, Kalina, Santacruz (East), Mumbai – 400 098, Maharashtra, India

Date of Birth/Age :

02.09.1976

Date of Appointment :

11.02.1997

DIN No.:

00121336

Other Directorship:

 

S.No.

CIN

Name of the Company

Current designation of the director

Date of appointment at current designation

Original date of appointment

Date of cessation

Company Status

Defaulting status

1

U24110MH1983PLC029560

HARMAN FINOCHEM LIMITED

Director

11/2/1997

11/2/1997

-

Active

NO

2

U67120MH1995PTC095124

LAXMI RAMUNA INVESTMENTS PRIVATE LIMITED

Director

1/10/1999

1/10/1999

-

Active

NO

3

U24230MH1989PTC132889

WELL WORTH MEDICINES PRIVATE LIMITED

Director

24/08/2001

24/08/2001

-

Active

NO

4

U25202MH1984PTC197665

KIRTI MERCHANTILE PRIVATE LIMITED

Director

2/1/2006

2/1/2006

-

Active

NO

5

U99999MH1974PTC017240

SUMMERSET GARDENS RESORT PRIVATE LIMITED

Additional director

24/11/2010

24/11/2010

-

Active

NO

 

 

Name :

Mr. Gurpreet Singh Bhupinder Singh Manhas

Designation :

Director

Address :

107-A, Vinaya Bhavya Complex, 159-A, CST Road, Kalina, Santacruz (East), Mumbai – 400 098, Maharashtra, India

Date of Birth/Age :

03.12.1979

Date of Appointment :

15.10.2007

DIN No.:

01885368

Other Directorship:

 

S.No.

CIN

Name of the Company

Current designation of the director

Date of appointment at current designation

Original date of appointment

Date of cessation

Company Status

Defaulting status

1

U24110MH1983PLC029560

HARMAN FINOCHEM LIMITED

Director

30/09/2008

15/10/2007

-

Active

NO

2

U99999MH1974PTC017240

SUMMERSET GARDENS RESORT PRIVATE LIMITED

Additional director

24/11/2010

24/11/2010

-

Active

NO

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

As on 30.09.2011

 

Names of Shareholders

 

No. of Shares

Bhupinder Singh Manhas

 

1935690

Bhupinder Singh Manhas (HUF)

 

118800

Harpreet Singh Manhas

 

390195

Gurpreet Singh Manhas

 

699855

Inderjeet Kaur Manhas

 

900000

Shyamsunder Shenoy

 

30

Unnikrishnan Parakkat

 

30

Wellworth Medicines Private Limited, India

 

690000

Kirti Mercantile Private Limited, India

 

29000

Total

 

4763600

 

 

Equity Share Break up (Percentage of Total Equity)

 

Category

Percentage

Directors or relatives of Directors

84.91

Other top fifty shareholders

15.09

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturing and Sale of Bulk Drugs and Pharmaceuticals

 

 

 

PRODUCTION STATUS 31.03.2011

 

Particulars

Unit

 

 

Installed Capacity

Riboflavin Phosphate Sodium

MT

 

 

24

Dexamethasone Phosphate Sodium

KG

 

 

120

Betamethasone Phosphate Sodium

KG

 

 

120

Betamethasone Valerate

KG

 

 

120

Metformine Hydrochloride B.P.

MT

 

 

240

Riboflavine (Vitamine B2)

MT

 

 

5

Phenobarbitone

MT

 

 

60

Phenobarbitone Sodium

MT

 

 

20

Allopurinol

MT

 

 

240

Dimethylamine

MT

 

 

1000

 

 

Particulars

 

 

 

Actual Production

Allopurinol

 

 

 

262132.02

Carisoprodol

 

 

 

10389.5

Divalproex Sodium

 

 

 

24553.32

Fenofibrate

 

 

 

2841.275

Glycopyrrolate

 

 

 

57.338

Ketamine Hydrochloride

 

 

 

185.08

Metformin Hydrochloride

 

 

 

2598492.86

Methadone Hydrochloride

 

 

 

316.4

Methyl Phenobarbital

 

 

 

412.792

Methylphenidate hydrochloride

 

 

 

53.685

Meprobamate

 

 

 

6159.13

Oxybutinin Hydrochloride

 

 

 

204.75

Oxiconazole Nitrate

 

 

 

47.5

Phenobarbitone

 

 

 

62954.845

Phenytain sodium usp

 

 

 

25256.1

Phenobarbitone Sodium I.P.

 

 

 

1247.555

Phenytoin Base EP/USP

 

 

 

46000

Riboflavine Phosphate Sodium-

 

 

 

15591.3

Valporic Acid

 

 

 

180.25

 

 

GENERAL INFORMATION

 

Customers :

Not Available

 

 

No. of Employees :

Not Available

 

 

Bankers :

Allahabad Bank, Industrial Finance Branch, Mumbai Samachar Marg, Fort, Mumbai – 400 023, Maharashtra, India

 

 

(Rs. In Millions)

Facilities :

Secured Loan

As on

31.03.2011

 

As on

31.03.2010

 

Working capital loans banks secured

44.799

51.047

Loans taken for vehicles secured

8.087

 

Total

52.886

51.047

Secured Loan

As on

31.03.2011

 

As on

31.03.2010

 

Deferred sales tax loan unsecured

0.291

0..375

Total

0.291

0.375

 

 

 

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

K U Kothari and Company

Chartered Accountants

Address :

A-1/205, Laram Centre, S V Road, Andheri (West), Mumbai – 400 058, Maharashtra, India

PAN.:

AADFK0855C

 

 

Subsidiaries :

Well Worth Medicines Private limited

CIN No.: U24230MH1989PTC132889

 

 

CAPITAL STRUCTURE

As on 30.09.2011

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

5,000,000

Equity Shares

Rs.10/- each

Rs.50.000 Millions

 

 

 

 

 

 

 

 

 


 

Issued, Subscribed & Paid-up Capital:

No. of Shares

Type

Value

Amount

 

 

 

 

4,763,600

Equity Shares

Rs.10/- each

Rs.47.636 Millions

 

 

 

 

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2011

31.03.2010

31.03.2009

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

47.636

47.636

47.636

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

1106.401

864.337

608.369

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

1154.037

911.973

656.005

LOAN FUNDS

 

 

 

1] Secured Loans

52.886

51.047

02.442

2] Unsecured Loans

0.291

0.375

3.075

TOTAL BORROWING

53.177

51.422

5.517

DEFERRED TAX LIABILITIES

0.000

0.000

0.000

 

 

 

 

TOTAL

1207.214

963.395

661.522

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

687.128

579.390

310.870

Capital work-in-progress

0.000

0.000

0.000

 

 

 

 

INVESTMENT

100.292

18.286

18.917

DEFERREX TAX ASSETS

9.029

5.363

4.007

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

92.638

37.310

38.467

 

Sundry Debtors

267.814

209.811

178.611

 

Cash & Bank Balances

39.896

125.782

73.401

 

Other current assets

0.000

0.000

143.760

 

Loans & Advances

689.301

508.616

297.675

Total Current Assets

1089.649

881.519

731.914

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

119.307

99.051

100.448

 

Other Current Liabilities

21.242

10.908

31.974

 

Provisions

538.335

411.204

271.764

Total Current Liabilities

678.884

521.163

404.186

Net Current Assets

410.765

360.356

327.728

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

1207.214

963.395

661.522

 


PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2011

31.03.2010

31.03.2009

 

SALES

 

 

 

 

 

Income

1367.745

1314.344

1075.815

 

 

Other Income

42.671

7.989

49.447

 

 

TOTAL                                     (A)

1410.416

1322.333

1125.262

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Consumption material changes inventories

636.931

592.963

 

 

Manufacturing service cost

190.170

171.420

 

 

 

Administrative Selling other Expenses

138.153

95.841

 

 

 

TOTAL                                     (B)

965.254

860.224

832.302

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

445.162

462.109

292.960

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

8.190

7.052

5.854

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

436.972

455.057

287.106

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

64.824

53.890

45.626

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

372.148

401.167

241.480

 

 

 

 

 

Less

TAX                                                                  (I)

121.780

136.866

83.459

 

 

 

 

 

 

PROFIT AFTER TAX (G-I)                                  (J)

250.368

264.301

158.021

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

835.627

579.658

429.996

 

 

 

 

 

Less

APPROPRIATIONS

 

 

 

 

Dividend

8.304

7.145

7.145

 

 

Tax on Dividend

 

1.187

1.214

 

BALANCE CARRIED TO THE B/S

1077.691

835.627

579.658

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

858.537

793.090

694.169

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

392.228

354.038

241.076

 

 

Capital Goods

NA

6.513

12.722

 

TOTAL IMPORTS

NA

360.551

253.798

 

 

 

 

 

 

Earnings Per Share (Rs.)

52.55

55.48

33.17

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2011

31.03.2010

31.03.2009

PAT / Total Income

(%)

1.77

1.99

14.04

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

27.20

30.52

22.44

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

34.15

45.50

32.99

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.32

0.43

0.36

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

0.58

0.057

0.61

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.60

1.69

1.81

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Check List by Info Agents

Available in Report (Yes / No)

1) Year of Establishment

Yes

2) Locality of the firm

Yes

3) Constitutions of the firm

Yes

4) Premises details

No

5) Type of Business

Yes

6) Line of Business•

Yes

7) Promoter’s background

Yes

8) No. of employees

No

9) Name of person contacted

No

10) Designation of contact person

No

11) Turnover of firm for last three years

No

12) Profitability for last three years

Yes

13) Reasons for variation <> 20%

--

14) Estimation for coming financial year

No

15) Capital in the business

Yes

16) Details of sister concerns

No

17) Major suppliers

No

18) Major customers

No

19) Payments terms

No

20) Export / Import details (if applicable)

No

21) Market information

--

22) Litigations that the firm / promoter

--

23) Banking Details

Yes

24) Banking facility details

Yes

25) Conduct of the banking account

--

26) Buyer visit details

--

27) Financials, if provided

Yes

28) Incorporation details, if applicable

Yes

29) Last accounts filed at ROC

Yes

30) Major Shareholders, if available

Yes

 

 

BUSINESS

 

During the year the company has rendered the effected sales to the tune of Rs.1367.745 Millions as against the previous year figure of Rs.1314.344 Millions. The company has earned profit before taxation worth Rs.372.148 Millions as against the previous year profit Rs.401.167 Millions.

 

 

Corporate identity number of the company

L24110MH1983PLC029560

Name of the company

HARMAN FINOCHEM LIMITED

Address of the registered office or of the principal place of  business in India of the company

107-A, Vinay Bhavya Complex, 159 A CST Road, Kalina Santacruz (East), Mumbai – 400 098, Maharashtra, India

This form is for

Modification of charge

Charge identification (ID) number of the charge to be modified

90239691

Type of charge

Immovable property

Particular of charge holder

Allahabad Bank, Industrial Finance Branch, Mumbai Samachar Marg, Fort, Mumbai – 400 023, Maharashtra, India

 

Nature of instrument creating charge

Supplemental Letter of Mortgagor Confirming Deposit of Title Deeds

Date of instrument Creating the charge

10.08.2007

Amount secured by the charge

Rs.90.000 Millions

Brief of the principal terms an conditions and extent and operation of the charge

Rate of Interest

CC & PC - PLR plus 3% p.a. shall be charged

FBN/FB, ILC/ FLC and Bank Guarantee - As per the Bank's circularized Instructions

 

Terms of Repayment

Repayment on Demand

 

Margin

CASH CREDIT   - 25% on Stocks (fully paid for) & 30% on Book Debts not older than 90 days.

FBN/FBP            - Nil

ILC/FLC              -10%

Bank Guarantee -10%

 

Extent and Operation of the charge

Exclusive first charge by way of Equitable Mortgage on immovable properties

 

Others

Limits enhanced from Rs.50.000 Millions to Rs.90.000

Short particulars of the property or asset(s) charged (including complete address and location of the property)

Equitable Mortgage on Company’s immovable properties bearing Plot No. E-9 situated at Chikalthana Industrial Area, Village Mhanadpur, Taluka and Sub Dist. and Dist. Aurangabad admeasuring 8306 Sq. Mtrs.

Date of instrument modifying the charge

04.03.2005

Particulars of the present modification

By present Modification, Equitable Mortgage on Company’s immovable properties situated at Chikalthana Industrial Area, Village Mhanadpur, Dist. Aurangabad has now increased from Rs.50.000 Millions to 90.000 Millions, to secure credit facilities detailed as under

Facilities              Amount

CC/PC              Rs.20.000 Millions)

FBN/FBP         (Rs.10.000 Millions )

ILC/FLC            Rs.70.000 Millions

Bk Guarantee  (Rs.10.000 Millions)

                        ------------------

Total                 Rs.90.000 Millions

 

 

 

FIXED ASSETS

 

·         Land

·         Factory Building

·         Flat and Staff Quarters

·         Office Equipment

·         Plant and Machinery

·         Electrical Fitting

·         Furniture and Fitting

·         Motor Car, Bus and Cycle

·         Computers

·         Office Premises

 

 

 

 

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.51.62

UK Pound

1

Rs.81.93

Euro

1

Rs.67.65

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILIRY

1~10

6

--LIQUIDITY

1~10

6

--LEVERAGE

1~10

5

--RESERVES

1~10

6

--CREDIT LINES

1~10

6

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

50

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.